Nice going, Intel
Things got rocky after that, with reported profitability falling by 11% over last year to $0.25 a share, but that was the result of a larger tax hit this time around and a $0.04-per-share hit for restructuring and asset impairment charges.
Throw it all into a blender, hit "frappe," and you've got one tasty smoothie, stale flash-memory fragments and all. Yes, the company's flash-memory business is still in a funk, but its flagship computer microprocessors are selling briskly. That's welcome news for investors of PC makers such as Dell
That's what Intel's report typically amounts to, anyway. Even if you don't own Intel, the company's numbers and guidance are enough to lift or sink the tech sector. It passed the buoyancy test last night, especially with its fairly upbeat outlook. Intel is looking to generate between $9 billion and $9.6 billion in the current quarter. That translates into a sequential dip, but the midpoint is just ahead of the $9.2 billion that Wall Street has been projecting. With Intel expecting gross margins to improve sequentially during the second quarter -- and even more in the second half of the year -- this bellwether is starting to sound more like a dinner bell for tech investors hungry for good news.
It will certainly go down better than that flash-chip smoothie you're now spitting out.
News to go
Shares of biotech upstart CV Therapeutics
Don't go dissing Office Depot
Wolverine World Wide
Let's play "Guess the Headline." Seagate Technology
- Hard Times for Hard-Drive Company
- Isn't Seagate Another Word for Watergate?
- Hard-Drive Maker Crashes
- How to Partition a Hard-Drive Stock
Have a great day out there.
Dell and Intel are Motley Fool Inside Value recommendations, CV Therapeutics is a Motley Fool Rule Breakers selection, and Dell is a Motley Fool Stock Advisor pick. Try any newsletter you like free for 30 days.
Longtime Fool contributor Rick Munarriz believes that breakfast is an important part of the day. He does not own shares in any of the companies in this story. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Fool has a disclosure policy.